FDA Adverse Event Malfunction Summary report: N

ACCESS

MDR report key: 3760989 · Received April 21, 2014

Report

Report Number
1416980-2014-12771
Event Type
Malfunction
Date Received
April 21, 2014
Date of Event
March 27, 2014
Report Date
March 27, 2014
Manufacturer
BIEFFE MEDITAL MANUFACTURING S.A.R.L. TUNIS
Product Code
FPA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
BR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). A BATCH REVIEW WILL BE PERFORMED. IF THE SAMPLE BECOMES AVAILABLE FOR EVALUATION OR ANY RELEVANT INFORMATION IS OBTAINED THAT IS RELATED TO THE REPORTED EVENT, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION SUMMARY: THE ACTUAL DEVICE WAS NOT RECEIVED FOR EVALUATION; THEREFORE, ANALYSIS OF THE ACTUAL SAMPLE COULD NOT BE PERFORMED. HOWEVER, A RETAINED SAMPLE WAS EVALUATED. VISUAL INSPECTION OF THE RETAINED SAMPLE DID NOT IDENTIFY ANY ABNORMALITIES THAT COULD HAVE CONTRIBUTED TO THE REPORTED CONDITION. FUNCTIONAL LEAK TESTING WAS PERFORMED ON THE RETAINED SAMPLE, AND NO LEAKS WERE OBSERVED. A BATCH REVIEW WAS CONDUCTED AND THERE WERE NO DEVIATIONS FOUND RELATED TO THIS REPORTED CONDITION DURING THE MANUFACTURE OF THIS LOT. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT A LIGHT SENSITIVE DRUG SET EXPERIENCED A LEAK. THE LOCATION IS UNKNOWN. THERE WAS NO PATIENT INVOLVEMENT. ADDITIONAL INFORMATION WAS REQUESTED AND IS NOT AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
240550 ACCESS SET, ADMINISTRATION, INTRAVASCULAR FPA BIEFFE MEDITAL MANUFACTURING S.A.R.L. TUNIS 13G25V116

Patients

Seq Age Sex Outcome Treatment
1